Biomarkers for Parkinson’s disease sought through imaging

More than 10 million people worldwide live with Parkinson’s disease, a progressive neurodegenerative disorder that affects movement, balance and thinking. Severity of the disease is measured through external symptoms, as there are no effective biomarkers that indicate the phase of the illness. A team of engineers, physicians and researchers at Washington University in St. Louis, […]

‘First-in-class’ tool for potential treatment of brain disorders

New methods to treat human brain disorders is one of the top priorities of the National Institutes of Health’s ambitious BRAIN Initiative. To find noninvasive tools that are equally or more effective is a kind of Holy Grail for neuroscience, and a biomedical engineer at Washington University in St. Louis has it in her sights. […]

Brain inflammation in Parkinson’s disease focus of $3.2 million grant

Parkinson’s disease usually is thought of as a movement disorder. People with Parkinson’s typically first develop a tremor in one hand, followed by slowed movement, stiffness and loss of balance. But within 10 years of diagnosis, more than three-quarters of Parkinson’s patients also develop cognitive problems such as difficulty with memory and with performing sequential […]

Perlmutter named scientific director of dystonia foundation

Joel S. Perlmutter, MD, the Elliot H. Stein Family Professor of Neurology at Washington University School of Medicine in St. Louis, has been named scientific director of the Dystonia Medical Research Foundation. Dystonia is a neurological disorder that causes excessive, involuntary muscle contractions and abnormal postures. An expert on Parkinson’s disease and related movement disorders […]